Personalized tactile cueing for Parkinson's (NCT05818189)
Improve walking speed and consistency
- Trial ID
- NCT05818189
- Official Title
- Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
- Goal
- Improve walking speed and consistency
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Oregon Health and Science University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Disease
- Interventions
- Personalized tactile cueing, Fixed tactile cueing
Summary For Families
The goal is to see whether a new, personalized wrist vibration timed to your own steps can make walking more automatic, lower activity in the front part of the brain, and reduce unevenness and slowness in gait. Sixty people with Parkinson's will be randomly assigned to receive either the step-synchronized wrist vibrations or vibrations at fixed intervals while researchers monitor brain activity and movement with wearable sensors, and they will also try wearing the device at home for a week to see if it helps and whether benefits stick. The trial seeks people aged 45 to 85 with typical Parkinson's at moderate stages who can stand or walk for two minutes without a walking aid, do not have deep brain stimulation implants, and do not have severe thinking problems or other conditions that would significantly affect walking.
Locations
- Oregon Health and Science University, Portland, Oregon, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Personalized tactile cueing. The goal is to see whether a new, personalized wrist vibration timed to your own steps can make walking more automatic, lower activity in the front part of the brain, and reduce unevenness and slowness in gait. Sixty people with Parkinson's will be randomly assigned to receive either the step-synchronized wrist vibrations or vibrations at fixed intervals while researchers monitor brain activity and movement with wearable sensors, and they will also try wearing the device at home for a week to see if it helps and whether benefits stick. The trial seeks people aged 45 to 85 with typical Parkinson's at moderate stages who can stand or walk for two minutes without a walking aid, do not have deep brain stimulation implants, and do not have severe thinking problems or other conditions that would significantly affect walking.
- Who can participate?
- Participants must be between 45 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 8 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Wearable / at-home monitoring (non-invasive). Confirm the full schedule with the study coordinator.